New birth control pill for fibroids and endometriosis shows promise in large trial
Disease control
Ongoing
This study tests whether a combination therapy with relugolix can prevent pregnancy in women with uterine fibroids or endometriosis. About 1,020 women aged 18 to 50 who are at risk of pregnancy will take the medication and be monitored for up to one year. The main goal is to see …
Phase: PHASE3 • Sponsor: Sumitomo Pharma Switzerland GmbH • Aim: Disease control
Last updated May 11, 2026 20:48 UTC